Moderna Launches Another mRNA-Based Injection Targeting The Common Cold RSV

Please Share This Story!

The genie of mRNA gene therapy injections is out of the bottle. Moderna's new shot targets the common cold RSV, an extremely low-risk virus, and the FDA has granted fast-track designation for rapid approval.

Technocracy News & Trends Premium Services are for Premium Access members only. Check it out!

Login Join Now

About the Editor

Patrick Wood
Patrick Wood is a leading and critical expert on Sustainable Development, Green Economy, Agenda 21, 2030 Agenda and historic Technocracy. He is the author of Technocracy Rising: The Trojan Horse of Global Transformation (2015) and co-author of Trilaterals Over Washington, Volumes I and II (1978-1980) with the late Antony C. Sutton.
16 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments